All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti – TechCrunch
TechCrunch |
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
TechCrunch A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of … |
Endpoints News |
Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectors
Endpoints News A gene therapy company headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The 2-year-old startup captured investors’ attention by suggesting it knows a better way to do gene transfer than the potentially toxic … Fidelity gets in on $100M round for gene therapy startup Generation BioBoston Business Journal Generation Bio Announces $100 Million Series B Financing to Advance GeneWave™ Platform for Re-Dosable Gene …Business Wire (press release) |
Business Insider |
We’re at the beginning of ‘a big new field of medicine’ — and one startup just got $53 million to supercharge it
Business Insider Biotech startup Senti Biosciences just raised $53 million from investors including New Enterprise Associates, 8VC, and Menlo Ventures. The startup’s aim is to create “circuits” using synthetic biology that could better program cell therapies to be … Synthetic Bio Startup Senti Raises $53M to Program Cells to Treat DiseaseXconomy NEA powers next-generation cell and gene therapy startup Senti to $53MA roundFierceBiotech |
The Hindu |
NCCS finds dual mechanism to help embryonic stem cells maintain pluripotency
The Hindu Embryonic stem cells are capable of generating all the cell types that compose the organs and systems of the human body. Now, researchers at Pune’s National Centre for Cell Science (NCCS) have found a dual mechanism that keeps specific genes off, which … |